#ASH19#bmtsm Horowitz: the BMT field realized long ago that every question can’t feasibly be addressed in trials. The @CIBMTR registry has become invaluable.
#ASH19#bmtsm Horowitz: when donor age implicated in outcomes, field shifted to selecting mostly donors <35yo. None of these studies could have been done without CUBMTR registry and they have had significant impact on patient outcomes.